No stock data available
Stocks to Watch Today, April 9: Investors seeking stocks to watch today should focus on key movers in real estate, finance, healthcare, and automotive sectors. Signature Global and Prestige Estates report strong pre-sales growth, while Shriram Finance attracts institutional interest from MUFG Bank.
Delhivery sees stake acquisition activity, highlighting logistics sector momentum. Healthcare stocks Zydus Lifesciences and Biocon gain from US FDA approvals for generic dapagliflozin, driving growth potential. Hyundai India’s price hike and NTPC’s MoU with EDF for nuclear projects add energy and automotive sector relevance. These developments make these companies top stocks to watch today for investors tracking market trends.
So, here’s the list of stocks to watch in today’s trading session:
| Company | Why in Focus |
| Signature Global | Pre-sales decline five per cent to Rs 1,540 crore |
| Delhivery | Investors buy 1.6 per cent stake for Rs 530 crore |
| ITC Hotels | GQG Partners sells 1.29 crore shares for Rs 197 crore |
| Ashiana Housing | Sales bookings more than double to Rs 1,289.70 crore |
| KEC International | Secures orders worth Rs 2,518 crore |
| Shriram Finance | MUFG Bank buys 20 per cent stake for Rs 39,618 crore |
| Max Healthcare Institute | Acquires 58.4 per cent stake in Kalinga Hospital for Rs 300 crore |
| Prestige Estates | Pre-sales rise 10 per cent to Rs 7,697 crore |
| Hyundai India | Vehicle prices to rise up to one per cent next month |
| NTPC | Signs MoU with EDF for new nuclear projects |
| Zydus Lifesciences | Gets US approval for generic dapagliflozin tablets |
| Biocon | Biocon Pharma approved for generic dapagliflozin in US |
Pre-sales decline five per cent to Rs 1,540 crore
Realty firm Signature Global Ltd reported a five per cent decline in pre-sales to Rs 1,540 crore in the fourth quarter of the previous fiscal year.
Delhivery
Investors buy 1.6 per cent stake for Rs 530 crore
A group of investors collectively acquired a 1.6 per cent stake in logistics company Delhivery from US-based venture capital firm Nexus Venture Partners for Rs 530 crore through open market transactions.
GQG Partners sells 1.29 crore shares for Rs 197 crore
Sales bookings more than double to Rs 1,289.70 crore
Realty firm Ashiana Housing Ltd saw its sales bookings more than double to Rs 1,289.70 crore during the fourth quarter of the last fiscal year, driven by stronger demand.
Secures orders worth Rs 2,518 crore
KEC International secured orders worth Rs 2,518 crore across its civil, transportation and distribution, and cable and conductors segments.
MUFG Bank buys 20 per cent stake for Rs 39,618 crore
Japan’s MUFG Bank acquired a 20 per cent stake in Shriram Finance Ltd for Rs 39,618 crore.
Acquires 58.4 per cent stake in Kalinga Hospital for Rs 300 crore
Max Healthcare Institute Ltd entered into a share purchase agreement to acquire a controlling stake of 58.4 per cent in Kalinga Hospital Ltd from Hospital Corporation of Orissa Inc., valuing the equity at Rs 300 crore, including a control premium.
Pre-sales rise 10 per cent to Rs 7,697 crore
Vehicle prices to rise up to one per cent next month
NTPC
Signs MoU with EDF for new nuclear projects
NTPC signed a non-binding Memorandum of Understanding with Électricité de France to explore collaboration in developing new nuclear power projects in India.
Gets US approval for generic dapagliflozin tablets
Zydus Lifesciences Ltd received final approval from the US health regulator for its generic version of dapagliflozin tablets, indicated for controlling blood sugar in adults with type 2 diabetes mellitus.
Biocon
Biocon Pharma approved for generic dapagliflozin in US
Biocon Ltd, through its subsidiary Biocon Pharma Ltd, received US health regulator approval for its generic version of dapagliflozin tablets, indicated for reducing blood sugar in adults with type 2 diabetes mellitus.
(Disclaimer: The above article is meant for informational purposes only, and should not be considered as any investment advice. ET NOW DIGITAL suggests its readers/audience to consult their financial advisors before making any money-related decisions.)
